Biotechnology : the science, the products, the government, the business / Ronald P. Evens
Tipo de material: TextoSeries Drugs and the pharmaceutical sciencesDetalles de publicación: Boca Raton : CRC, 2021 Descripción: XIX, 182 p. ; 24 cmISBN: 9780367497026Tema(s): Biotecnología farmacéutica | Industria farmacéuticaResumen: The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies.FeaturesComprehensive coverage of biotechnology science topics used in development and manufacturingAddresses all the scientific technologies within biotechnology responsible for products on the market and the pipelinePresents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolvedTipo de ítem | Biblioteca de origen | Signatura | Estado | Fecha de vencimiento | Código de barras | Reserva de ítems |
---|---|---|---|---|---|---|
Monografías | 01. BIBLIOTECA CAMPUS JEREZ | ENF-1603 (Navegar estantería(Abre debajo)) | Disponible Ubicación en estantería | Bibliomaps® | 3745092210 | ||
Monografías | 02. BIBLIOTECA CAMPUS PUERTO REAL | 615/EVE/bio (Navegar estantería(Abre debajo)) | Disponible Ubicación en estantería | Bibliomaps® | 3744949594 |
Bibliografía. - índice
The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies.FeaturesComprehensive coverage of biotechnology science topics used in development and manufacturingAddresses all the scientific technologies within biotechnology responsible for products on the market and the pipelinePresents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved
No hay comentarios en este titulo.